골수증식 종양의 2017년 WHO 진단기준 주요 변경 사항의 이해

키워드

참고문헌 (36)

1. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues" (2017), IARC Press
2. Tefferi A, "Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis", Blood, 124, pp.2507~2513 (2014)[DOI]
3. Tefferi A, "An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms", Leukemia, 28, pp.1407~1413 (2014)[DOI]
4. Barbui T, "Myeloproliferative neoplasms: morphology and clinical practice", Am J Hematol, 91, pp.430~433 (2016)[DOI]
5. Gianelli U, "Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms", Mod Pathol, 27, pp.814~822 (2014)[DOI]
6. Gisslinger H, "Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET study, a randomized controlled trial", Blood, 121, pp.1720~1728 (2013)[DOI]
7. Madelung AB, "World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience", Am J Hematol, 88, pp.1012~1016 (2013)[DOI]
8. Thiele J, "Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification", Blood, 117, pp.5710~5718 (2011)[DOI]
9. Barbui T, "Masked polycythemia vera (mPV): results of an international study", Am J Hematol, 89, pp.52~54 (2014)[DOI]
10. Barosi G, "Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis", PLoS One, 7, pp.e35631~ (2012)[DOI]
11. Gianelli U, "Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms", Expert Rev Hematol, 7, pp.255~264 (2014)[DOI]
12. Gisslinger H, "Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria", Leukemia, 30, pp.1126~1132 (2016)[DOI]
13. Byun JM, "Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013", Ann Hematol, 96, pp.373~381 (2017)[DOI]
14. 최철원, "Guidelines for the management of myeloproliferative neoplasms", The Korean Journal of Internal Medicine, 30(6), pp.771~788 (2015), 대한내과학회[DOI]
15. Hanfstein B, "Response-related predictors of survival in CML", Ann Hematol, 94(Suppl 2), pp.S227~S239 (2015)[DOI]
16. Rea D, "First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia", Leukemia, 26, pp.2254~2259 (2012)[DOI]
17. Fabarius A, "Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV", Blood, 118, pp.6760~6768 (2011)[DOI]
18. Maxson JE, "Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML", N Engl J Med, 368, pp.1781~1790 (2013)[DOI]
19. Pardanani A, "CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia", Leukemia, 27, pp.1870~1873 (2013)[DOI]
20. Dong F, "The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia", acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation, 2001, pp.167, 6447~6452
21. Cui Y, "CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia", J Hematol Oncol, 7, pp.77~ (2014)[DOI]
22. Elliott MA, "Chronic neutrophilic leukemia 2016: update on diagnosis, molecular genetics, prognosis, and management", Am J Hematol, 91, pp.341~349 (2016)[DOI]
23. Lasho TL, "Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib", Leukemia, 28, pp.1363~1365 (2014)[DOI]
24. Elliott MA, "ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia", Am J Hematol, 90, pp.653~656 (2015)[DOI]
25. Alvarez-Larran A, "Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes", Eur J Haematol, 96, pp.83~89 (2016)[DOI]
26. Barbui T, "Masked polycythemia vera diagnosed according to WHO and BCSH classification", Am J Hematol, 89, pp.199~202 (2014)[DOI]
27. Barbui T, "Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients", Am J Hematol, 89, pp.588~590 (2014)[DOI]
28. Barbui T, "Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification", Leukemia, 28, pp.2092~2094 (2014)[DOI]
29. Thiele J, "The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis", Curr Hematol Malig Rep, 4, pp.33~40 (2009)[DOI]
30. Thiele J, "Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?", Histol Histopathol, 20, pp.633~644 (2005)
31. Thiele J, "Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients", Ann Hematol, 82, pp.148~152 (2003)
32. Kvasnicka HM, "The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera", Semin Thromb Hemost, 32(4), pp.362~371 (2006)[DOI]
33. Thiele J, "Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders", Semin Thromb Hemost, 32, pp.219~230 (2006)[DOI]
34. Tefferi A, "Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies", J Clin Oncol, 29, pp.573~582 (2011)
35. Tefferi A, "CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons", Leukemia, 28, pp.1472~1477 (2014)[DOI]
36. Thiele J, "European consensus on grading bone marrow fibrosis and assessment of cellularity", Haematologica, 90, pp.1128~1132 (2005)

관련 논문AI추천